Quinoline-based imidazole-fused heterocycles as new inhibitors of 15-lipoxygenase

被引:16
|
作者
Dianat, Shima [1 ]
Moghimi, Setareh [2 ,3 ]
Mahdavi, Mohammad [4 ]
Nadri, Hamid [5 ]
Moradi, Alireza [5 ]
Firoozpour, Loghman [4 ]
Emami, Saeed [6 ,7 ]
Mouradzadegun, Arash [1 ]
Shafiee, Abbas [2 ,3 ]
Foroumadi, Alireza [2 ,3 ,4 ]
机构
[1] Shahid Chamran Univ, Dept Chem, Fac Sci, Ahvaz, Iran
[2] Univ Tehran Med Sci, Fac Pharm, Dept Med Chem, Tehran, Iran
[3] Univ Tehran Med Sci, Pharmaceut Sci Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Drug Design & Dev Res Ctr, Tehran, Iran
[5] Shahid Sadoughi Univ Med Sci, Fac Pharm, Dept Med Chem, Yazd, Iran
[6] Mazandaran Univ Med Sci, Fac Pharm, Dept Med Chem, Sari, Iran
[7] Mazandaran Univ Med Sci, Fac Pharm, Pharmaceut Sci Res Ctr, Sari, Iran
基金
美国国家科学基金会;
关键词
Docking study; enzyme inhibitors; 15-lipoxygenase; imidazo[1; 2-a]pyridine; imidazo[2; 1-b]thiazole; POTENT INHIBITORS; 5-LIPOXYGENASE; 12/15-LIPOXYGENASE; ATHEROSCLEROSIS; DERIVATIVES; DOCKING;
D O I
10.1080/14756366.2016.1206087
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of 2-chloro-quinoline-based imidazopyridines 6a-l and imidazothiazoles 6m-o bearing a bulky alkylamine side chain were synthesized as soybean 15-LOX inhibitors. The target compounds 6a-o were prepared via one-pot reaction of 2-chloroquinoline-3-carbaldehyde (3), heteroaromatic amidine 4, and alkyl isocyanides 5, in the presence of NH4Cl. All compounds showed significant anti-15-LOX activity (IC50 values40M). Among the title compounds, the imidazo[2,1-b]thiazole derivative 6n bearing a tert-butylamine moiety showed the highest activity against soybean 15-LOX enzyme.
引用
收藏
页码:205 / 209
页数:5
相关论文
共 50 条
  • [1] Catechol based inhibitors of 15-lipoxygenase
    Tait, BD
    Dyer, RD
    Auerbach, BJ
    Bornemeier, D
    GuildsZamarka, L
    Oxender, M
    Roth, BD
    Trivedi, BK
    Cornicelli, JA
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (01) : 93 - 96
  • [2] 15-Lipoxygenase inhibitors: a patent review
    Sadeghian, Hamid
    Jabbari, Atena
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (01) : 65 - 88
  • [3] 15-LIPOXYGENASE - A RAPID, SENSITIVE ASSAY FOR LIPOXYGENASE INHIBITORS
    KINGSTON, WP
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1981, 74 (04) : P919 - P920
  • [4] Inhibitors of 15-lipoxygenase from orange peel
    Malterud, KE
    Rydland, KM
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2000, 48 (11) : 5576 - 5580
  • [5] The importance of 15-lipoxygenase inhibitors in cancer treatment
    Ala Orafaie
    Maryam Moghaddam Matin
    Hamid Sadeghian
    [J]. Cancer and Metastasis Reviews, 2018, 37 : 397 - 408
  • [6] Indolizines as novel potent inhibitors of 15-lipoxygenase
    Gundersen, LL
    Malterud, KE
    Negussie, AH
    Rise, F
    Teklu, S
    Ostby, OB
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (24) : 5409 - 5415
  • [7] Metal-Free Electrochemical Trifluoromethylation of Imidazole-Fused Heterocycles with Trifluoromethyl Thianthrenium Triflate
    Ge, Chang
    Qiao, Lipeng
    Zhang, Yuyang
    Sun, Kai
    An, Jiangzhen
    Peng, Mei
    Chen, Xiaolan
    Qu, Lingbo
    Yu, Bing
    [J]. CHINESE JOURNAL OF CHEMISTRY, 2024, 42 (15) : 1679 - 1685
  • [8] The importance of 15-lipoxygenase inhibitors in cancer treatment
    Orafaie, Ala
    Matin, Maryam Moghaddam
    Sadeghian, Hamid
    [J]. CANCER AND METASTASIS REVIEWS, 2018, 37 (2-3) : 397 - 408
  • [9] Design and synthesis of new esters of terpenoid alcohols as 15-lipoxygenase inhibitors
    Sadeghian, Hamid
    Seyedi, Seyed Mohammad
    Jafari, Zeinab
    [J]. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2018, 21 (07) : 738 - 744
  • [10] Quinoline-based HIV Integrase Inhibitors
    Musiol, Robert
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (10) : 1835 - 1849